ASTH vs PATH
Astrana Health Inc (ASTH) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Astrana Health Inc (ASTH) is a medical care facilities company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported ASTH revenue for 2024-12-31 was $2.03B. Net income was $49.9M. Revenue was up 46.7% from 2023-12-31 to 2024-12-31. ASTH currently screens at market cap $1.13B and trailing P/E 33.5.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
ASTH currently screens at market cap $1.13B and trailing P/E 33.5. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the ASTH and PATH stock pages for the full models.
Not investment advice.